Fosaprepitant Dimeglumine

Fosaprepitant Dimeglumine
Product Description

A niche API used in its finished form (injectable) in adults and children to prevent nausea and vomiting caused by cancer chemotherapy. Available for all global markets along with DMF support.

Apothecon Pharmaceuticals

  • IN
  • 2018
    On CPHI since
Specifications
  • CAS Registry Number
    265721-04-8

Apothecon Pharmaceuticals

  • IN
  • 2018
    On CPHI since

More Products from Apothecon Pharmaceuticals (23)

  • Sevelamer Hydrochloride

    Product Sevelamer Hydrochloride

    A niche API used in its finished form (tablet) for the treatment of hyperphosphatemia in patients with chronic kidney disease. Available for all global markets along with DMF support.

  • Trientine Hydrochloride

    Product Trientine Hydrochloride

    An orphan drug API is used in its finished form (capsules) for the treatment of the rare occurring Wilson’s disease. Available for select markets along with DMF support.

  • Ferric Carboxy Maltose

    Product Ferric Carboxy Maltose

    Ferric carboxymaltose (Ferinject(R)), a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron to target tissues. Administered intravenously, it is effective in the treatment of iron-deficiency anaemia, delivering a replenishme...
  • Miglustat

    Product Miglustat

    Miglustat is a rare drug used majorly for the treatment of Gaucher's disease, (a condition in which a certain fatty substance is not broken down normally in the body and instead builds up in some organs and causes liver, spleen, bone, and blood problems). Miglustat is in a class of medications called enzym...
  • Carmustine

    Product Carmustine

    A niche oncology API used in its finished form (injectable) for the treatment of brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors. Available for all global markets except the US along with DMF support.

  • Fomepizole

    Product Fomepizole

    An orphan drug API used in its finished form (injectable) is the only known antidote for methanol and ethylene glycol poisoning in the world. Available for all global markets along with DMF support.

  • Ropivacaine (base)

    Product Ropivacaine (base)

    A niche API used in its finished form (injectable) for production of local or regional anesthesia or analgesia for surgery, for oral surgery procedures, for diagnostic and therapeutic procedures, and for obstetrical procedures Available for all global markets along with DMF support.

  • Ropivacaine Hydrochloride

    Product Ropivacaine Hydrochloride

    A niche API used in its finished form (injectable) to administer local anesthesia, regional anesthesia, or surgical anesthesia.. Available for all global markets along with DMF support.

  • Benztropine Mesylate

    Product Benztropine Mesylate

    A niche API used in its finished form (tablet and injectable) for the treatment of parkinsonism or Parkinson's disease, including tremor due to the disease, drug-induced extrapyramidal symptoms and chronic sialorrhea (chronic drooling) in developmentally-disabled patients. Available for all global market...
  • Penicillamine

    Product Penicillamine

    A niche API used in its finished form (capsule) is an anti-rheumatic drug used to treat patients with active rheumatoid arthritis. It also is classified as a metal binding (chelating) agent used for treating Wilson's disease, Available for all global markets except the US along with DMF support.

  • Phenoxybenzamine Hydrochloride

    Product Phenoxybenzamine Hydrochloride

    A niche API used in its finished form (capsule) is used as an alpha blocker indicated for the treatment of high blood pressure and heavy sweating due to a certain tumor of the adrenal glands (pheochromocytoma). Available for all global markets along with DMF support.

  • Nicardipine Hydrochloride

    Product Nicardipine Hydrochloride

    A niche API used in its finished form (injectable) is used as a calcium channel blocker indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable. Available for all global markets along with DMF support.